January 29-31, 2019 | San Francisco


Gero is a data-driven longevity company that leverages unique physics-based approach to aging turned into cutting-edge modeling platform for targets and biomarkers identification. Having a pipeline of longevity therapeutics in development, we also provide health and mortality risk assessment models for insurance and healthcare industries. Recent results include newly identified compounds extending life in model animals, blood circulating protein targets validated in mice, and wearable-based biomarkers of aging and frailty.